Bleeding avoidance strategies: Consensus and controversy

Journal of the American College of Cardiology

Volumn 58, Issue 1, 2011, Pages 1-10

  Dauerman, Harold L ^a   Rao, Sunil V ^b   Resnic, Frederic S ^d   Applegate, Robert J ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c WAKE FOREST BAPTIST HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

bleeding; PCI; radial; vascular closure device

Indexed keywords

ABCIXIMAB; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; HEPARIN; HIRULOG; PROTAMINE;

ARTERIOTOMY; ARTICLE; BLEEDING; CATHETER THROMBOSIS; COMBINATION CHEMOTHERAPY; COMPRESSION THERAPY; COST EFFECTIVENESS ANALYSIS; DEVICE; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; FALSE ANEURYSM; GASTROINTESTINAL HEMORRHAGE; HEART CATHETERIZATION; HEMATOMA; HOSPITAL COST; HOSPITALIZATION; HUMAN; LOW DRUG DOSE; META ANALYSIS (TOPIC); MONOTHERAPY; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT SATISFACTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SAFETY; SURGICAL APPROACH; VASCULAR ACCESS; VASCULAR DISEASE;

EID: 79959525970     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.02.039     Document Type: Review

References (95)

1. S.P. Marso, A.P. Amin, and J.A. House Association between use of bleeding avoidance strategies and risk of periprocedural bleeding among patients undergoing percutaneous coronary intervention JAMA 303 2010 2156 2164
2. M.R. Patel, H. Jneid, and C.P. Derdeyn Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association Circulation 122 2010 1882 1893
3. G. Ndrepepa, P.B. Berger, and J. Mehilli Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697 (Pubitemid 351221218)
4. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782 (Pubitemid 44268228)
5. F.S. Resnic, N. Arora, M. Matheny, and M.R. Reynolds A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention Am J Cardiol 99 2007 766 770 (Pubitemid 46365595)
6. S.V. Rao, J.G. Jollis, and R.A. Harrington Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes JAMA 292 2004 1555 1562 (Pubitemid 39314961)
7. S.V. Manoukian, F. Feit, and R. Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial J Am Coll Cardiol 49 2007 1362 1368 (Pubitemid 46476844)
8. J.A. Spertus, K.A. Eagle, H.M. Krumholz, K.R. Mitchell, and S.L. Normand American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care J Am Coll Cardiol 45 2005 1147 1156 (Pubitemid 40432453)
9. B.J. Doyle, H.H. Ting, and M.R. Bell Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005 J Am Coll Cardiol Intv 1 2008 202 209 (Pubitemid 351506552)
10. M.T. Roe, J.C. Messenger, and W.S. Weintraub Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention J Am Coll Cardiol 56 2010 254 263
11. R.J. Applegate, M.T. Sacrinty, and M.A. Kutcher Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007 J Am Coll Cardiovasc Intv 1 2008 317 326 (Pubitemid 351804185)
12. B. Ahmed, W.D. Piper, and D. Malenka Significantly improved vascular complications among women undergoing percutaneous coronary intervention: a report from the Northern New England Percutaneous Coronary Intervention Registry Circ Cardiovasc Interv 2 2009 423 429
13. H.L. Dauerman, R.J. Applegate, and D.J. Cohen Vascular closure devices: the second decade J Am Coll Cardiol 50 2007 1617 1626 (Pubitemid 47562669)
14. S.V. Rao, K. O'Grady, and K.S. Pieper A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes J Am Coll Cardiol 47 2006 809 816 (Pubitemid 43243106)
15. E. Nikolsky, G.W. Stone, and A.J. Kirtane Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial J Am Coll Cardiol 54 2009 1293 1302
16. T.D. Kinnaird, E. Stabile, and G.S. Mintz Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935 (Pubitemid 37214804)
17. M.A. Gaglia Jr, R. Torguson, and M.A. Gonzalez Correlates and consequences of gastrointestinal bleeding complicating percutaneous coronary intervention Am J Cardiol 106 2010 1069 1074
18. K.A. Fox, K. Carruthers, and P.G. Steg Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The Global Registry of Acute Coronary Events Eur Heart J 31 2010 667 675
19. V.L. Serebruany, and D. Atar Assessment of bleeding events in clinical trials-proposal of a new classification Am J Cardiol 99 2007 288 290 (Pubitemid 46072771)
20. S.R. Steinhubl, A. Kastrati, and P.B. Berger Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs Am Heart J 154 2007 3 11 (Pubitemid 46924806)
21. R. Mehran, S.J. Pocock, and E. Nikolsky A risk score to predict bleeding in patients with acute coronary syndromes J Am Coll Cardiol 55 2010 2556 2566
22. H.D. White, P.E. Aylward, and R. Gallo Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial Am Heart J 159 2010 110 116
23. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
24. S.V. Rao, J. Eikelboom, and P.G. Steg Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group Am Heart J 158 2009 881 886
25. G.W. Stone, H.D. White, and E.M. Ohman Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial Lancet 369 2007 907 919 (Pubitemid 46400858)
26. S.S. Jolly, D.P. Faxon, and K.A. Fox Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial J Am Coll Cardiol 54 2009 468 476
27. F. Kiemeneij, G.J. Laarman, D. Odekerken, T. Slagboom, and R. van der Wieken A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the Access study J Am Coll Cardiol 29 1997 1269 1275 (Pubitemid 27201945)
28. D.A. Sherev, R.E. Shaw, and B.N. Brent Angiographic predictors of femoral access site complications: implication for planned percutaneous coronary intervention Catheter Cardiovasc Interv 65 2005 196 202 (Pubitemid 40791511)
29. Z.G. Turi Optimizing vascular access: routine femoral angiography keeps the vascular complication away Catheter Cardiovasc Interv 65 2005 203 204 (Pubitemid 40791512)
30. J.C. Blankenship, C. Balog, and S.K. Sapp Reduction in vascular access site bleeding in sequential abciximab coronary intervention trials Catheter Cardiovasc Interv 57 2002 476 483 (Pubitemid 35424125)
31. J.R. Buchler, E.E. Ribeiro, and J.L. Falcao A randomized trial of 5 versus 7 French guiding catheters for transfemoral percutaneous coronary stent implantation J Interv Cardiol 21 2008 50 55 (Pubitemid 351178398)
32. R. Gallo, S.R. Steinhubl, H.D. White, and G. Montalescot Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial Catheter Cardiovasc Interv 73 2009 319 325
33. G. Schnyder, N. Sawhney, B. Whisenant, S. Tsimikas, and Z.G. Turi Common femoral artery anatomy is influenced by demographics and comorbidity: implications for cardiac and peripheral invasive studies Catheter Cardiovasc Interv 53 2001 289 295 (Pubitemid 32622554)
34. J. Fitts, L.P. Ver, P. Hofmaster, and D. Malenka Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications J Interv Cardiol 21 2008 273 278 (Pubitemid 351703980)
35. A.H. Seto, M.S. Abu-Fadel, and J.M. Sparling Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial) J Am Coll Cardiol Intv 3 2010 751 758
36. S.V. Rao, F.S. Ou, and T.Y. Wang Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry J Am Coll Cardiol Intv 1 2008 379 386
37. S.S. Jolly, S. Amlani, M. Hamon, S. Yusuf, and S.R. Mehta Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials Am Heart J 157 2009 132 140
38. S.S. Jolly, S. Yusuf, J. Cairns RIVAL Trial Group Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Lancet 377 2011 1409 1420
39. O.F. Bertrand, S.V. Rao, and S. Pancholy Transradial approach for coronary angiography and interventions: results of the first international transradial practice survey J Am Coll Cardiol Intv 3 2010 1022 1031
40. P. Agostoni, G.G. Biondi-Zoccai, and M.L. de Benedictis Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials J Am Coll Cardiol 44 2004 349 356 (Pubitemid 38950594)
41. Y. Louvard, T. Lefevre, A. Allain, and M. Morice Coronary angiography through the radial or the femoral approach: the CARAFE study Catheter Cardiovasc Interv 52 2001 181 187 (Pubitemid 32115130)
42. A. Vorobcsuk, A. Konyi, and D. Aradi Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction: systematic overview and meta-analysis Am Heart J 158 2009 814 821
43. C. Spaulding, T. Lefevre, and F. Funck Left radial approach for coronary angiography: results of a prospective study Cathet Cardiovasc Diagn 39 1996 365 370 (Pubitemid 26423982)
44. C.J. Cooper, R.A. El-Shiekh, and D.J. Cohen Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison Am Heart J 138 1999 430 436 (Pubitemid 29428763)
45. D.S. Pinto, G.W. Stone, and C. Shi Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes J Am Coll Cardiol 52 2008 1758 1768
46. S.V. Rao, M.G. Cohen, D.E. Kandzari, O.F. Bertrand, and I.C. Gilchrist The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions J Am Coll Cardiol 55 2010 2187 2195
47. S. Pancholy, J. Coppola, T. Patel, and M. Roke-Thomas Prevention of radial artery occlusion-patent hemostasis evaluation trial (PROPHET study): a randomized comparison of traditional versus patency documented hemostasis after transradial catheterization Catheter Cardiovasc Interv 72 2008 335 340
48. M. Brueck, D. Bandorski, W. Kramer, M. Wieczorek, R. Holtgen, and H. Tillmanns A randomized comparison of transradial versus transfemoral approach for coronary angiography and angioplasty J Am Coll Cardiol Intv 2 2009 1047 1054
49. J.M. Cubero, J. Lombardo, and C. Pedrosa Radial compression guided by mean artery pressure versus standard compression with a pneumatic device (RACOMAP) Catheter Cardiovasc Interv 73 2009 467 472
50. P.R. Stella, F. Kiemeneij, G.J. Laarman, D. Odekerken, T. Slagboom, and R. van der Wieken Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty Cathet Cardiovasc Diagn 40 1997 156 158 (Pubitemid 27057541)
51. J.C. Blankenship, A.S. Hellkamp, F.V. Aguirre, S.L. Demko, E.J. Topol, and R.M. Califf Vascular access site complications after percutaneous coronary intervention with abciximab in the Evaluation of c7E3 for the Prevention of Ischemic Complications (EPIC) trial Am J Cardiol 81 1998 36 40 (Pubitemid 28046839)
52. S. Schulz, J. Mehilli, and F.J. Neumann ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention Eur Heart J 31 2010 2482 2491
53. R. Dumaine, M. Borentain, and O. Bertel Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials Arch Intern Med 167 2007 2423 2430 (Pubitemid 350258448)
54. G. Montalescot, H.D. White, and R. Gallo Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention N Engl J Med 355 2006 1006 1017 (Pubitemid 44343544)
55. C.M. Gibson, S.A. Murphy, and G. Montalescot Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial J Am Coll Cardiol 49 2007 2238 2246 (Pubitemid 46856824)
56. H.D. White, N.S. Kleiman, and K.W. Mahaffey Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial Am Heart J 152 2006 1042 1050 (Pubitemid 44872990)
57. D. Brieger, F. Van de Werf, and A. Avezum Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention The Global Registry of Acute Coronary Events (GRACE) Am Heart J 153 2007 960 969 (Pubitemid 46809853)
58. M. Cohen, G.N. Levine, and K.S. Pieper Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial Catheter Cardiovasc Interv 75 2010 928 935
59. S.R. Mehta, C.B. Granger, and J.W. Eikelboom Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial J Am Coll Cardiol 50 2007 1742 1751 (Pubitemid 47600591)
60. S.R. Mehta, W.E. Boden, and J.W. Eikelboom Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials Circulation 118 2008 2038 2046
61. K.A. Fox, J.P. Bassand, and S.R. Mehta Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes Ann Intern Med 147 2007 304 310 (Pubitemid 351664557)
62. P.G. Steg, S.S. Jolly, and S.R. Mehta Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial JAMA 304 2010 1339 1349
63. G.W. Stone, B.T. McLaurin, and D.A. Cox Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216 (Pubitemid 44791162)
64. R. Mehran, A.J. Lansky, and B. Witzenbichler Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
65. C.M. Gibson, D.A. Morrow, and S.A. Murphy A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECTTIMI 30 trial J Am Coll Cardiol 47 2006 2364 2373 (Pubitemid 43884775)
66. G. Parodi, G. De Luca, and G. Moschi Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy J Thromb Thrombolysis 30 2010 446 451
67. G. Parodi, A. Migliorini, and R. Valenti Comparison of bivalirudin and unfractionated heparin plus protamine in patients with coronary heart disease undergoing percutaneous coronary intervention (from the Antithrombotic Regimens aNd Outcome [ARNO] trial) Am J Cardiol 105 2010 1053 1059
68. A.Y. Fung, J. Saw, and A. Starovoytov Abbreviated infusion of eptifibatide after successful coronary intervention: the BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial J Am Coll Cardiol 53 2009 837 845
69. Y.L. Gu, M.L. Fokkema, and M.A. Kampinga Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration Trials 10 2009 90
70. H.D. White, D.P. Chew, and J.W. Hoekstra Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol 51 2008 1734 1741 (Pubitemid 351621989)
71. G. Dangas, R. Mehran, and G. Guagliumi Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol 54 2009 1438 1446
72. G. Parodi, D. Antoniucci, and E. Nikolsky Impact of bivalirudin therapy in high-risk patients with acute myocardial infarction: 1-year results from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial J Am Coll Cardiol Intv 3 2010 796 802
73. G.D. Dangas, A. Caixeta, R. Mehran HORIZONS-AMI Trial Investigators Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction Circulation 123 2011 1745 1756
74. R. Iijima, G. Ndrepepa, and J. Mehilli Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention Eur Heart J 30 2009 290 296
75. S. Schulz, J. Mehilli, and G. Ndrepepa Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial Eur Heart J 31 2010 582 587
76. A. Kastrati, F.J. Neumann, and J. Mehilli Bivalirudin versus unfractionated heparin during percutaneous coronary intervention N Engl J Med 359 2008 688 696
77. R.G. Nader, J.C. Garcia, K. Drushal, and T. Pesek Clinical evaluation of SyvekPatch in patients undergoing interventional, EPS and diagnostic cardiac catheterization procedures J Invasive Cardiol 14 2002 305 307 (Pubitemid 34651237)
78. R.J. Applegate, M.T. Sacrinty, and M.A. Kutcher Propensity score analysis of vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention using thrombin hemostatic patch-facilitated manual compression J Invasive Cardiol 19 2007 164 170 (Pubitemid 46558002)
79. M. Koreny, E. Riedmuller, M. Nikfardjam, P. Siostrzonek, and M. Mullner Arterial puncture closing devices compared with standard manual compression after cardiac catheterization: systematic review and meta-analysis JAMA 291 2004 350 357 (Pubitemid 38101608)
80. E. Nikolsky, R. Mehran, and A. Halkin Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis J Am Coll Cardiol 44 2004 1200 1209 (Pubitemid 39208874)
81. P.T. Vaitkus A meta-analysis of percutaneous vascular closure devices after diagnostic catheterization and percutaneous coronary intervention J Invasive Cardiol 16 2004 243 246 (Pubitemid 38637895)
82. D.R. Tavris, S. Dey, and B. Albrecht-Gallauresi Risk of local adverse events following cardiac catheterization by hemostasis device use: phase II J Invasive Cardiol 17 2005 644 650
83. R.J. Applegate, M. Sacrinty, and M.A. Kutcher Vascular complications with newer generations of angioseal vascular closure devices J Interv Cardiol 19 2006 67 74
84. J.O. Balzer, D. Scheinert, T. Diebold, M. Haufe, T.J. Vogl, and G. Biamino Postinterventional transcutaneous suture of femoral artery access sites in patients with peripheral arterial occlusive disease: a study of 930 patients Catheter Cardiovasc Interv 53 2001 174 181 (Pubitemid 32532176)
85. B.S. Warren, S.G. Warren, and S.D. Miller Predictors of complications and learning curve using the Angio-Seal closure device following interventional and diagnostic catheterization Catheter Cardiovasc Interv 48 1999 162 166 (Pubitemid 29458313)
86. N. Arora, M.E. Matheny, C. Sepke, and F.S. Resnic A propensity analysis of the risk of vascular complications after cardiac catheterization procedures with the use of vascular closure devices Am Heart J 153 2007 606 611 (Pubitemid 46440677)
87. T.A. Sanborn, R. Ebrahimi, and S.V. Manoukian Impact of femoral vascular closure devices and antithrombotic therapy on access site bleeding in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial Circ Cardiovasc Interv 3 2010 57 62
88. B. Chevalier, B. Lancelin, and R. Koning Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial Catheter Cardiovasc Interv 58 2003 285 291 (Pubitemid 36259212)
89. S.J. Pocock, R. Mehran, and T.C. Clayton Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial Circulation 121 2010 43 51
90. D.R. Tavris, B. Albrecht Gallauresi, and B. Lin Risk of local adverse events following cardiac catheterization by hemostasis device use and gender J Invasive Cardiol 16 2004 459 464 (Pubitemid 39244890)
91. S.G. Ellis, D. Bhatt, S. Kapadia, D. Lee, M. Yen, and P.L. Whitlow Correlates and outcomes of retroperitoneal hemorrhage complicating percutaneous coronary intervention Catheter Cardiovasc Interv 67 2006 541 545
92. S. Bangalore, N. Arora, and F.S. Resnic Vascular closure device failure: frequency and implications: a propensity-matched analysis Circ Cardiovasc Interv 2 2009 549 556
93. A.D. Kugelmass, D.J. Cohen, P.P. Brown, A.W. Simon, E.R. Becker, and S.D. Culler Hospital resources consumed in treating complications associated with percutaneous coronary interventions Am J Cardiol 97 2006 322 327 (Pubitemid 43133043)
94. M. Hamon, L.H. Rasmussen, and S.V. Manoukian Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial EuroIntervention 5 2009 115 120
95. T.Y. Wang, L. Xiao, and K.P. Alexander Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding Circulation 118 2008 2139 2145